BackNOV Overview
NOV Inc

NOV Target Price

Analysts' average 12-month price target for NOV is $22.

Get informed when a big investor buys or sells

+ Follow

Share Price

$21.39

Average Target Price

$21.801.9% upside

5 analysts in the last 4 months

High: $26 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-15Morgan Stanley$211.8% downsideOpen
2026-07-08Susquehanna$222.9% upsideOpen
2026-06-04Capital One Financial$2621.6% upsideOpen
2026-06-03Goldman Sachs$1911.2% downsideOpen
2026-05-07BarclaysDavid Anderson$211.8% downsideOpen
2026-04-29Susquehanna$2412.2% upsideOpen
2026-04-15Morgan Stanley$206.5% downsideOpen
2026-02-09Piper SandlerDerek Podhaizer$1815.8% downsideOpen
2026-02-06Evercore ISIJason Bandel$1911.2% downsideOpen
2026-02-06Stifel Nicolaus$211.8% downsideOpen
2026-02-06Susquehanna$211.8% downsideOpen
2026-01-15RBC CapitalKeith Mackey$211.8% downsideOpen
2026-01-14Goldman Sachs$1720.5% downsideOpen
2026-01-07SusquehannaCharles Minervino$206.5% downsideOpen
2025-12-18Piper SandlerDerek Podhaizer$1720.5% downsideOpen
2025-12-17Barclays$1529.9% downsideOpen
2025-12-15Morgan StanleyJoe Laetsch$1625.2% downsideOpen
2025-11-11BarclaysDavid Anderson$1339.2% downsideOpen
2025-11-05Goldman SachsAti Modak$1434.5% downsideOpen
2025-10-30Barclays$1434.5% downsideOpen
2025-10-29Stifel Nicolaus$1911.2% downsideOpen
2025-10-29RBC Capital$1911.2% downsideOpen
2025-10-28Raymond JamesJames Rollyson$1720.5% downsideOpen
2025-07-30Susquehanna$1720.5% downsideOpen
2025-04-15Stifel NicolausStephen Gengaro$237.5% upsideOpen
2025-03-24RBC CapitalKeith Mackey$222.9% upsideOpen
2024-12-18BarclaysDavid Anderson$1243.9% downsideOpen
2024-10-11Stifel NicolausStephen Gengaro$2516.9% upsideOpen
2024-10-10BMO CapitalPhillip Jungwirth$206.5% downsideOpen
2024-09-16Morgan StanleyDaniel Kutz$237.5% upsideOpen
2024-07-30BarclaysDavid Anderson$206.5% downsideOpen
2023-02-08Susquehanna$2935.6% upsideOpen
2022-07-29Morgan Stanley$1911.2% downsideOpen
2022-07-13Morgan Stanley$1815.8% downsideOpen
2022-07-13Goldman Sachs$1625.2% downsideOpen
2022-06-08Barclays$222.9% upsideOpen
2022-05-02Barclays$206.5% downsideOpen
2022-02-04Evercore ISIJames West$222.9% upsideOpen
2021-12-09Cowen & Co.Marc Bianchi$1911.2% downsideOpen
2021-10-11Morgan StanleyConnor Lynagh$1720.5% downsideOpen
2021-07-19BMO CapitalPhillip Jungwirth$1529.9% downsideOpen
2021-05-04Coker PalmerVaibhav Vaishnav$1243.9% downsideOpen

NOV (NOV) FAQ

NOV posts a target price of $22. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $22 for NOV means covering analysts, on average, see the stock 1.9% upside of $21.39 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for NOV's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; NOV's other metric pages and overview cover the third.

Judging NOV against Industrials peers is usually better than using a market-wide rule of thumb. Business models inside Industrials are more comparable, which makes gaps in target price easier to interpret. Start with $22 here, then scan peer and history charts to see if the gap is persistent.